Contact Us

BioSynTech Malaysia Group Sdn Bhd
Revongen Corporation Center,
Level 17, Top Glove Tower,
No. 16, Persiaran Setia Dagang,
Setia Alam, Seksyen U13,
40170 Shah Alam, Selangor Darul Ehsan, Malaysia.


T : +6 03 8025 1603
F : +6 03 8025 1637
E :

Social Media

New Small Molecules from MCE for August 2020

New Small Molecules from MCE for August 2020

MCE (MedChemExpress) provides a wide range of lifescience biochemicals, including more than 25,000 bioactive compounds, recombinant proteins, dye reagents, peptides and natural compounds for laboratory and scientific use.

• Over 25,000 bioactive molecules in stock
• Target 375 key proteins in 20+ signaling pathways
• Quality reports (LC/MS, NMR and HPLC) for each product
• Release more than 500 of the newest biochemicals per month
• High purity & competitive prices
• Data sheet with detailed biological information
• Delivery within 24 hours
• Complement System
AMY-101 acetate

AMY-101 acetate (Cp40 acetate), a peptidic inhibitor of the central complement component C3 (KD = 0.5 nM), inhibits naturally occurring periodontitis in non-human primates (NHPs). AMY-101 acetate (Cp40 acetate) exhibits a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation.

Compound Screening Libraries



50 specific libraries for high throughput screening (HTS) and high content screening (HCS). Optimized for drug screening and new indication research.

• AMPK Activator
IM156                                          CAS No. : 1422365-94-3

IM156 (HL156A; HL271 acetate), a chemical derivative of metformin (HY-B0627), is a potent AMPK activator that increases AMPK phosphorylation. IM156 attenuates aging-associated cognitive impairment in animal model. IM156 is a potent oxidative phosphorylation (OXPHOS) inhibitor which can be used for the research of solid tumors.

Cell Signaling Pathway

• CDK Inhibitor
K00546                                       CAS No. : 443798-47-8

K00546 is a potent CDK1 and CDK2 inhibitor with IC50s of 0.6 nM and 0.5 nM for CDK1/cyclin B and CDK2/cyclin A, respectively. K00546 is also a potent CDC2-like kinase 1 (CLK1) and CLK3 inhibitor with IC50s of 8.9 nM and 29.2 nM, respectively.

• Recent Publication Citing used MCE

1. Cell. 2020 Aug 6;182(3):545-562.e23.
2. Cancer Cell. 2020 Jul 30;S1535-6108(20)30369-X. doi:10.1016/j.ccell.2020.07.008.
3. Cell Metab. 2020 Aug 4;32(2):287-300.e7.
4. Cell Stem Cell. 2020 Jul 14;S1934-5909(20)30288-5. doi:10.1016/j.stem.2020.06.021.

• Microtubule/Tubulin Inhibitor
Batabulin sodium

Batabulin sodium (T138067 sodium) is an antitumor agent, which binds covalently and selectively to a subset of the β-tubulin isotypes, thereby disrupting microtubule polymerization. Batabulin sodium affects cell morphology and leads to cell-cycle arrest ultimately induces apoptotic cell death.

• iGluR Antagonist
TCN 201                              CAS No. : 852918-02-6

TCN 201 is a potent, selective and non-competitive antagonist of GluN1/GluN2A NMDA receptor, with a pIC50 of 6.8. TCN 201 is selective for GluN1/GluN2A NMDA receptor over GluN1/GluN2B NMDA receptor (pIC50<4.3).


Other New Products This Month

Infliximab (TNF Receptor) Phenidone (COX) Pramipexole (Dopamine Receptor)
Ropivacaine (Sodium Channel) Loxoprofen (COX) CRT0044876 (DNA/RNA Synthesis)
GI-530159 (Potassium Channel) Ganciclovir (CMV) Win 18446 (Aldehyde Dehydrogenase (ALDH))
Gemigliptin (Dipeptidyl Peptidase) …